299 related articles for article (PubMed ID: 36406171)
1. Early detection of urinary bladder carcinogens in rats by immunohistochemistry for γ-H2AX: a review from analyses of 100 chemicals.
Toyoda T; Ogawa K
J Toxicol Pathol; 2022 Oct; 35(4):283-298. PubMed ID: 36406171
[TBL] [Abstract][Full Text] [Related]
2. Dose dependency of γ-H2AX formation in the rat urinary bladder treated with genotoxic and nongenotoxic bladder carcinogens.
Yamada T; Toyoda T; Matsushita K; Morikawa T; Ogawa K
J Appl Toxicol; 2020 Sep; 40(9):1219-1227. PubMed ID: 32203627
[TBL] [Abstract][Full Text] [Related]
3. Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for γ-H2AX.
Yamada T; Toyoda T; Matsushita K; Cho YM; Akagi JI; Morikawa T; Mizuta Y; Ogawa K
Arch Toxicol; 2021 Feb; 95(2):715-726. PubMed ID: 33211169
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of γ-H2AX as a method of early detection of urinary bladder carcinogenicity in mice.
Sone M; Toyoda T; Cho YM; Akagi JI; Matsushita K; Mizuta Y; Morikawa T; Nishikawa A; Ogawa K
J Appl Toxicol; 2019 Jun; 39(6):868-876. PubMed ID: 30701581
[TBL] [Abstract][Full Text] [Related]
5. Early detection of hepatocarcinogens in rats by immunohistochemistry of γ-H2AX.
Toyoda T; Sone M; Matsushita K; Akane H; Akagi JI; Morikawa T; Mizuta Y; Cho YM; Ogawa K
J Toxicol Sci; 2023; 48(6):323-332. PubMed ID: 37258237
[TBL] [Abstract][Full Text] [Related]
6. Early Detection of Genotoxic Urinary Bladder Carcinogens by Immunohistochemistry for γ-H2AX.
Toyoda T; Cho YM; Akagi J; Mizuta Y; Hirata T; Nishikawa A; Ogawa K
Toxicol Sci; 2015 Dec; 148(2):400-8. PubMed ID: 26338220
[TBL] [Abstract][Full Text] [Related]
7. Role of γ-H2AX as a biomarker for detection of bladder carcinogens in F344 rats.
Suzuki S; Gi M; Toyoda T; Kato H; Naiki-Ito A; Kakehashi A; Ogawa K; Takahashi S; Wanibuchi H
J Toxicol Pathol; 2020 Oct; 33(4):279-285. PubMed ID: 33239845
[TBL] [Abstract][Full Text] [Related]
8. Mucosal damage and γ-H2AX formation in the rat urinary bladder induced by aromatic amines with structures similar to o-toluidine and o-anisidine.
Toyoda T; Kobayashi T; Miyoshi N; Matsushita K; Akane H; Morikawa T; Ogawa K
Arch Toxicol; 2023 Dec; 97(12):3197-3207. PubMed ID: 37773275
[TBL] [Abstract][Full Text] [Related]
9. Persistent γ-H2AX Formation and Expression of Stem Cell Markers in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Bladder Carcinogenesis in Rats.
Yamada T; Toyoda T; Matsushita K; Akane H; Morikawa T; Cho YM; Ogawa K
Toxicol Sci; 2022 Aug; 189(1):51-61. PubMed ID: 35771629
[TBL] [Abstract][Full Text] [Related]
10. Distinct differences in the mechanisms of mucosal damage and γ-H2AX formation in the rat urinary bladder treated with o-toluidine and o-anisidine.
Toyoda T; Matsushita K; Morikawa T; Yamada T; Miyoshi N; Ogawa K
Arch Toxicol; 2019 Mar; 93(3):753-762. PubMed ID: 30656379
[TBL] [Abstract][Full Text] [Related]
11. Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds.
Qu M; Xu H; Li W; Chen J; Zhang Y; Xu B; Li Z; Liu T; Guo L; Xie J
Arch Toxicol; 2021 Nov; 95(11):3559-3573. PubMed ID: 34510228
[TBL] [Abstract][Full Text] [Related]
12. γ-H2AX formation in the urinary bladder of rats treated with two norharman derivatives obtained from o-toluidine and aniline.
Toyoda T; Totsuka Y; Matsushita K; Morikawa T; Miyoshi N; Wakabayashi K; Ogawa K
J Appl Toxicol; 2018 Apr; 38(4):537-543. PubMed ID: 29143974
[TBL] [Abstract][Full Text] [Related]
13. EpCAM and APN expression in combination with γ-H2AX as biomarkers for detecting hepatocarcinogens in rats.
Akagi JI; Cho YM; Toyoda T; Mizuta Y; Ogawa K
Cancer Sci; 2023 Dec; 114(12):4763-4769. PubMed ID: 37858605
[TBL] [Abstract][Full Text] [Related]
14. Detection of γ-H2AX, a Biomarker for DNA Double-strand Breaks, in Urinary Bladders of N -Butyl- N -(4-Hydroxybutyl)-Nitrosamine-Treated Rats.
Toyoda T; Akagi J; Cho YM; Mizuta Y; Onami S; Suzuki I; Ogawa K
J Toxicol Pathol; 2013 Jun; 26(2):215-21. PubMed ID: 23914065
[TBL] [Abstract][Full Text] [Related]
15. Toxicological effects of two metabolites derived from o-toluidine and o-anisidine after 28-day oral administration to rats.
Toyoda T; Kobayashi T; Miyoshi N; Matsushita K; Akane H; Morikawa T; Ogawa K
J Toxicol Sci; 2022; 47(11):457-466. PubMed ID: 36328536
[TBL] [Abstract][Full Text] [Related]
16. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
[TBL] [Abstract][Full Text] [Related]
17. Short-term detection of gastric genotoxicity using the DNA double-strand break marker γ-H2AX.
Okabe A; Kiriyama Y; Suzuki S; Sakurai K; Teramoto A; Kato H; Naiki-Ito A; Tahara S; Takahashi S; Kuroda M; Sugioka A; Tsukamoto T
J Toxicol Pathol; 2019 Apr; 32(2):91-99. PubMed ID: 31092975
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
19. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
20. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
